Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient dosed in phase III study of BCX-7353 for HAE

March 16, 2018

Medshine Discovery discloses novel PDE4 inhibitors

March 16, 2018

Ovid Therapeutics' OV-101 given FDA fast track status

March 16, 2018

Abeona's ABO-202 receives FDA rare pediatic disease designation

March 16, 2018

Exelixis completes submission of sNDA in U.S. for Cabometyx in HCC

March 16, 2018

Ionis and Akcea enter worldwide license agreement to commercialize inotersen

March 16, 2018

FDA awards breakthrough therapy designation to erdafitinib for metastatic urothelial cancer

March 16, 2018

Massive Bio announces SYNERGY-AI registry

March 16, 2018

NGM-282 shown to reduce liver fat in patients with NASH

March 16, 2018

PTC Therapeutics provides update on FIREFISH study in spinal muscular atrophy

March 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...